Qiagen Articles

US FDA approves companion diagnostic for Tarceva, and new indication for the Roche drug

15 May 2013

Boehringer Ingelheim's afatinib NDA gets priority review in USA

16 January 2013

US FDA approves Erbitux as first-line treatment in KRAS wild-type EGFR

9 July 2012

Qiagen to buy 61% stake in Ipsogen, aiming to take full control of the molecular diagnostics firm

10 July 2011

Australian diagnostics firm Cellestis gets $355 million offer from Qiagen

5 April 2011

Qiagen anticipates growth in India, as it sets up subsidiary

28 January 2011

S.A.N.E Vax calls on US Senator Grassley to expand NCI ethics investigation

30 November 2010

Batch of licensing deals announced by Merck KGaA, Novartis and Roche

13 July 2010

Showing 1-8 of 8 articles

Go to beginningPrevious
  • 1
NextGo to end